ImmunologybioRxivPreprint
Targeting Anti-HLA Class I and II Antibodies with CAR-B Cell Therapy: A Novel Strategy to Mitigate Graft Rejection and Platelet Refractoriness
This paper proposes CAR-B cell therapy targeting anti-HLA Class I and II antibodies to reduce graft rejection and transfusion reactions by specifically neutralizing these antibodies and T cell responses.
DOI 10.1101/2025.02.20.639042